RxSight
RXST
RXST
228 hedge funds and large institutions have $1.98B invested in RxSight in 2024 Q2 according to their latest regulatory filings, with 52 funds opening new positions, 75 increasing their positions, 79 reducing their positions, and 19 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding in top 10
Funds holding in top 10: →
more capital invested
Capital invested by funds: $ → $
16% more funds holding
Funds holding: 197 → 228 (+31)
1.79% more ownership
Funds ownership: 82.74% → 84.53% (+1.8%)
5% less repeat investments, than reductions
Existing positions increased: 75 | Existing positions reduced: 79
Holders
228
Holding in Top 10
7
Calls
$4.25M
Puts
$752K
Top Buyers
| 1 | +$29.1M | |
| 2 | +$19.5M | |
| 3 | +$18.2M | |
| 4 |
Baillie Gifford & Co
Edinburgh,
United Kingdom
|
+$17.6M |
| 5 |
BlackRock
New York
|
+$17.5M |
Top Sellers
| 1 | -$35.1M | |
| 2 | -$33.8M | |
| 3 | -$11.2M | |
| 4 |
Millennium Management
New York
|
-$10M |
| 5 |
JP Morgan Chase
New York
|
-$7.58M |